Houlihan Lokey (NYSE: HLI) insider transactions
In the twelve months to 10 November 2026, executives and directors of Houlihan Lokey reported 5 open-market sales of 13,265 shares ($2.1m) and 1 open-market purchase of 4,020 shares ($500,570), by 4 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 1 October 2026 | Reichert Thomas | Director | Grant or award | +925 | — | 925 | Form 4 |
| 10 September 2026 | Crain Christopher M | General Counsel | Conversion | +1,000 | — | 1,000 | Form 4 |
| 10 September 2026 | Crain Christopher M | General Counsel | Open-market sale | −1,000 | $140.15 | 0 | Form 4 |
| 3 August 2026 | Alley J Lindsey | Chief Financial Officer | Open-market purchase | +4,020 | $124.52 | 4,020 | Form 4 |
| 21 May 2026 | Mund Ronald Scott | Director | Grant or award | +476 | — | 969 | Form 4 |
| 21 May 2026 | Schriesheim Robert A | Director | Grant or award | +1,129 | — | 29,111 | Form 4 |
| 21 May 2026 | Zuber Paul Andrew | Director | Grant or award | +797 | — | 7,005 | Form 4 |
| 21 May 2026 | Zucker Gillian Beth | Director | Grant or award | +996 | — | 6,529 | Form 4 |
| 21 May 2026 | Bassey Ekpedeme M | Director | Grant or award | +797 | — | 6,424 | Form 4 |
| 21 May 2026 | Walker Cyrus D. | Director | Grant or award | +996 | — | 7,111 | Form 4 |
| 21 May 2026 | Beiser Scott L | Co-chairman | Conversion | +6,265 | — | 6,265 | Form 4 |
| 21 May 2026 | Beiser Scott L | Co-chairman | Open-market sale | −6,265 | $150.26 | 0 | Form 4 |
| 1 April 2026 | Crain Christopher M | General Counsel | Conversion, 10b5-1 plan | +500 | — | 500 | Form 4 |
| 1 April 2026 | Crain Christopher M | General Counsel | Open-market sale, 10b5-1 plan | −500 | $143.40 | 0 | Form 4 |
| 6 February 2026 | Schriesheim Robert A | Director | Open-market sale | −5,000 | $170.86 | 27,982 | Form 4 |
| 2 January 2026 | Crain Christopher M | General Counsel | Conversion, 10b5-1 plan | +500 | — | 500 | Form 4 |
| 2 January 2026 | Crain Christopher M | General Counsel | Open-market sale, 10b5-1 plan | −500 | $174.17 | 0 | Form 4 |
| 5 December 2025 | Gold Irwin | Co-chairman | Conversion | +5,000 | — | 5,000 | Form 4 |
| 5 December 2025 | Gold Irwin | Co-chairman | Gift | −5,000 | — | 0 | Form 4 |
| 26 November 2025 | Crain Christopher M | General Counsel | Conversion | +1,200 | — | 1,200 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Houlihan Lokey page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.